Cargando…

Isolation of tumour stem-like cells from benign tumours

BACKGROUND: Cancerous stem-like cells (CSCs) have been implicated as cancer-initiating cells in a range of malignant tumours. Diverse genetic programs regulate CSC behaviours, and CSCs from glioblastoma patients are qualitatively distinct from each other. The intrinsic connection between the presenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Q, Yuan, X, Tunici, P, Liu, G, Fan, X, Xu, M, Hu, J, Hwang, J Y, Farkas, D L, Black, K L, Yu, J S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720199/
https://www.ncbi.nlm.nih.gov/pubmed/19568241
http://dx.doi.org/10.1038/sj.bjc.6605142
_version_ 1782170114501640192
author Xu, Q
Yuan, X
Tunici, P
Liu, G
Fan, X
Xu, M
Hu, J
Hwang, J Y
Farkas, D L
Black, K L
Yu, J S
author_facet Xu, Q
Yuan, X
Tunici, P
Liu, G
Fan, X
Xu, M
Hu, J
Hwang, J Y
Farkas, D L
Black, K L
Yu, J S
author_sort Xu, Q
collection PubMed
description BACKGROUND: Cancerous stem-like cells (CSCs) have been implicated as cancer-initiating cells in a range of malignant tumours. Diverse genetic programs regulate CSC behaviours, and CSCs from glioblastoma patients are qualitatively distinct from each other. The intrinsic connection between the presence of CSCs and malignancy is unclear. We set out to test whether tumour stem-like cells can be identified from benign tumours. METHODS: Tumour sphere cultures were derived from hormone-positive and -negative pituitary adenomas. Characterisation of tumour stem-like cells in vitro was performed using self-renewal assays, stem cell-associated marker expression analysis, differentiation, and stimulated hormone production assays. The tumour-initiating capability of these tumour stem-like cells was tested in serial brain tumour transplantation experiments using SCID mice. RESULTS: In this study, we isolated sphere-forming, self-renewable, and multipotent stem-like cells from pituitary adenomas, which are benign tumours. We found that pituitary adenoma stem-like cells (PASCs), compared with their differentiated daughter cells, expressed increased levels of stem cell-associated gene products, antiapoptotic proteins, and pituitary progenitor cell markers. Similar to CSCs isolated from glioblastomas, PASCs are more resistant to chemotherapeutics than their differentiated daughter cells. Furthermore, differentiated PASCs responded to stimulation with hypothalamic hormones and produced corresponding pituitary hormones that are reflective of the phenotypes of the primary pituitary tumours. Finally, we demonstrated that PASCs are pituitary tumour-initiating cells in serial transplantation animal experiments. CONCLUSION: This study for the first time indicates that stem-like cells are present in benign tumours. The conclusions from this study may have applications to understanding pituitary tumour biology and therapies, as well as implications for the notion of tumour-initiating cells in general.
format Text
id pubmed-2720199
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-27201992010-07-21 Isolation of tumour stem-like cells from benign tumours Xu, Q Yuan, X Tunici, P Liu, G Fan, X Xu, M Hu, J Hwang, J Y Farkas, D L Black, K L Yu, J S Br J Cancer Molecular Diagnostics BACKGROUND: Cancerous stem-like cells (CSCs) have been implicated as cancer-initiating cells in a range of malignant tumours. Diverse genetic programs regulate CSC behaviours, and CSCs from glioblastoma patients are qualitatively distinct from each other. The intrinsic connection between the presence of CSCs and malignancy is unclear. We set out to test whether tumour stem-like cells can be identified from benign tumours. METHODS: Tumour sphere cultures were derived from hormone-positive and -negative pituitary adenomas. Characterisation of tumour stem-like cells in vitro was performed using self-renewal assays, stem cell-associated marker expression analysis, differentiation, and stimulated hormone production assays. The tumour-initiating capability of these tumour stem-like cells was tested in serial brain tumour transplantation experiments using SCID mice. RESULTS: In this study, we isolated sphere-forming, self-renewable, and multipotent stem-like cells from pituitary adenomas, which are benign tumours. We found that pituitary adenoma stem-like cells (PASCs), compared with their differentiated daughter cells, expressed increased levels of stem cell-associated gene products, antiapoptotic proteins, and pituitary progenitor cell markers. Similar to CSCs isolated from glioblastomas, PASCs are more resistant to chemotherapeutics than their differentiated daughter cells. Furthermore, differentiated PASCs responded to stimulation with hypothalamic hormones and produced corresponding pituitary hormones that are reflective of the phenotypes of the primary pituitary tumours. Finally, we demonstrated that PASCs are pituitary tumour-initiating cells in serial transplantation animal experiments. CONCLUSION: This study for the first time indicates that stem-like cells are present in benign tumours. The conclusions from this study may have applications to understanding pituitary tumour biology and therapies, as well as implications for the notion of tumour-initiating cells in general. Nature Publishing Group 2009-07-21 2009-06-30 /pmc/articles/PMC2720199/ /pubmed/19568241 http://dx.doi.org/10.1038/sj.bjc.6605142 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Molecular Diagnostics
Xu, Q
Yuan, X
Tunici, P
Liu, G
Fan, X
Xu, M
Hu, J
Hwang, J Y
Farkas, D L
Black, K L
Yu, J S
Isolation of tumour stem-like cells from benign tumours
title Isolation of tumour stem-like cells from benign tumours
title_full Isolation of tumour stem-like cells from benign tumours
title_fullStr Isolation of tumour stem-like cells from benign tumours
title_full_unstemmed Isolation of tumour stem-like cells from benign tumours
title_short Isolation of tumour stem-like cells from benign tumours
title_sort isolation of tumour stem-like cells from benign tumours
topic Molecular Diagnostics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720199/
https://www.ncbi.nlm.nih.gov/pubmed/19568241
http://dx.doi.org/10.1038/sj.bjc.6605142
work_keys_str_mv AT xuq isolationoftumourstemlikecellsfrombenigntumours
AT yuanx isolationoftumourstemlikecellsfrombenigntumours
AT tunicip isolationoftumourstemlikecellsfrombenigntumours
AT liug isolationoftumourstemlikecellsfrombenigntumours
AT fanx isolationoftumourstemlikecellsfrombenigntumours
AT xum isolationoftumourstemlikecellsfrombenigntumours
AT huj isolationoftumourstemlikecellsfrombenigntumours
AT hwangjy isolationoftumourstemlikecellsfrombenigntumours
AT farkasdl isolationoftumourstemlikecellsfrombenigntumours
AT blackkl isolationoftumourstemlikecellsfrombenigntumours
AT yujs isolationoftumourstemlikecellsfrombenigntumours